表紙
市場調查報告書
商品編碼
1031578

基因學的全球市場:產品·各類服務,各技術,各終端用戶,各應用領域,各地區-預測(—2026年)-COVID-19的累積性的影響

Genomics Market Research Report by Product & Service, by Technology, by End-User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球基因學市場規模在2020年估算為201億美元,2021年達到233億1000萬美元,並將以16.30%的年複合成長率增長,到2026年前將達到497億7000萬美元。

本報告提供全球基因學市場相關調查分析,提供COVID-19的影響,促進因素,阻礙因素,市場機會,課題,產品·各類服務,各技術,各終端用戶,各應用領域,各地區市場資訊,競爭情形,企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 假設
  • 利害關係者

第2章 調查手法

  • 定義:調查目的
  • 決策:調查設計
  • 準備:調查設備
  • 收集:資料來源
  • 分析:資料解釋
  • 制定:資料檢驗
  • 公開:調查報告
  • 重複:報告的更新

第3章 摘要整理

第4章 市場概要

  • COVID-19累積的影響

第5章 市場動態

  • 促進因素
    • 政府的基因計劃數增加
    • 基因醫學的採用擴大
    • 農業基因組學遺傳工具的開發
  • 阻礙因素
    • 設備與消耗品的高成本
  • 市場機會
    • 新生兒的遺傳基因篩檢計劃的成長
    • 序列與創新產品銷售和服務的採用
  • 課題
    • 技術人員有限

第6章 基因學市場:產品·各類服務

  • 消耗品
  • 服務
  • 系統和軟體

第7章 基因學市場:各技術

  • 微陣列
  • 核酸提取純化
  • PCR
  • 序列

第8章 基因學市場:各終端用戶

  • 醫院和診所
  • 製藥及生物科技企業
  • 調查中心,學術及政府機關,

第9章 基因學市場:各應用領域

  • 農業及動物調查
  • 診斷
  • 藥物研發與開發

第10章 基因學市場:南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 基因學市場:亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第12章 基因學市場:歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析:主要參與者
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第14章 企業的實用性簡介

  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Beijing Genomics Institute(BGI)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Helix OpCo, LLC
  • Illumina, Inc.
  • IntegraGen SA
  • Merck Group
  • Myriad Genetics, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Personal Genome Diagnostics Inc.
  • Personalis, Inc.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

第15章 附錄

  • 討論指南
  • 許可證和價格
目錄
Product Code: MRR-434CCDA04CDE

The Global Genomics Market size was estimated at USD 20.10 billion in 2020 and expected to reach USD 23.31 billion in 2021, at a CAGR 16.30% to reach USD 49.77 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Genomics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product & Service, the market was studied across Consumables, Services, and Systems & Software.

Based on Technology, the market was studied across Microarray, Nucleic Acid Extraction & Purification, PCR, and Sequencing.

Based on End-User, the market was studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers and Academic & Government Institutes,.

Based on Application, the market was studied across Agriculture & Animal Research, Diagnostics, and Drug Discovery & Development.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Genomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Genomics Market, including 23andMe, Inc., Agilent Technologies, Inc., Beijing Genomics Institute (BGI), Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Helix OpCo, LLC, Illumina, Inc., IntegraGen SA, Merck Group, Myriad Genetics, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Personal Genome Diagnostics Inc., Personalis, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Genomics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Genomics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Genomics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Genomics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Genomics Market?
  • 6. What is the market share of the leading vendors in the Global Genomics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Genomics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Rising number of government genome projects
    • 5.2.2. Growing adoption of genomic medicine
    • 5.2.3. Development of genetic tools in agrigenomics
  • 5.3. Restraints
    • 5.3.1. High cost of equipment and consumables
  • 5.4. Opportunities
    • 5.4.1. Growth of newborn genetic screening programs
    • 5.4.2. Adoption of sequencing and innovative product launch and services
  • 5.5. Challenges
    • 5.5.1. Limited skilled and trained personnel

6. Genomics Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Services
  • 6.4. Systems & Software

7. Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray
  • 7.3. Nucleic Acid Extraction & Purification
  • 7.4. PCR
  • 7.5. Sequencing

8. Genomics Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research Centers and Academic & Government Institutes,

9. Genomics Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture & Animal Research
  • 9.3. Diagnostics
  • 9.4. Drug Discovery & Development

10. Americas Genomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Genomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Genomics Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. 23andMe, Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Beijing Genomics Institute (BGI)
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. Eppendorf AG
  • 14.7. Eurofins Scientific
  • 14.8. F. Hoffmann-La Roche Ltd.
  • 14.9. Helix OpCo, LLC
  • 14.10. Illumina, Inc.
  • 14.11. IntegraGen SA
  • 14.12. Merck Group
  • 14.13. Myriad Genetics, Inc.
  • 14.14. Novogene Co., Ltd.
  • 14.15. Oxford Nanopore Technologies
  • 14.16. Pacific Biosciences of California, Inc.
  • 14.17. Personal Genome Diagnostics Inc.
  • 14.18. Personalis, Inc.
  • 14.19. Quest Diagnostics Incorporated
  • 14.20. Thermo Fisher Scientific Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENOMICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 3. GLOBAL GENOMICS MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2020 VS 2026 (USD BILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2026
  • FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD BILLION)
  • FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 14. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 16. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL GENOMICS MARKET SIZE, BY PCR, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL GENOMICS MARKET SIZE, BY PCR, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 25. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2026
  • FIGURE 27. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 34. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 36. GLOBAL GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2026 (USD BILLION)
  • FIGURE 37. GLOBAL GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2026 (USD BILLION)
  • FIGURE 39. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2026 (USD BILLION)
  • FIGURE 41. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. AMERICAS GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 43. ARGENTINA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 44. BRAZIL GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 45. CANADA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 46. MEXICO GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 47. UNITED STATES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 48. ASIA-PACIFIC GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 49. AUSTRALIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 50. CHINA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 51. INDIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 52. INDONESIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 53. JAPAN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 54. MALAYSIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 55. PHILIPPINES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 56. SINGAPORE GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 57. SOUTH KOREA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 58. TAIWAN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 59. THAILAND GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 61. FRANCE GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 62. GERMANY GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 63. ITALY GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 64. NETHERLANDS GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 65. QATAR GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 66. RUSSIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 67. SAUDI ARABIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 68. SOUTH AFRICA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 69. SPAIN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 70. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 71. UNITED KINGDOM GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 72. GLOBAL GENOMICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 73. GLOBAL GENOMICS MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GENOMICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL GENOMICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2026 (USD BILLION)
  • TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 6. GLOBAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD BILLION)
  • TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY PCR, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2018-2026 (USD BILLION)
  • TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
  • TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 21. AMERICAS GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 22. ARGENTINA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 23. BRAZIL GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 24. CANADA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 25. MEXICO GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 26. UNITED STATES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 27. ASIA-PACIFIC GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 28. AUSTRALIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 29. CHINA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 30. INDIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 31. INDONESIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 32. JAPAN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 33. MALAYSIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 34. PHILIPPINES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 35. SINGAPORE GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 36. SOUTH KOREA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 37. TAIWAN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 38. THAILAND GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 40. FRANCE GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 41. GERMANY GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 42. ITALY GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 43. NETHERLANDS GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 44. QATAR GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 45. RUSSIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 46. SAUDI ARABIA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 47. SOUTH AFRICA GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 48. SPAIN GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 49. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 50. UNITED KINGDOM GENOMICS MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 51. GLOBAL GENOMICS MARKET: SCORES
  • TABLE 52. GLOBAL GENOMICS MARKET: BUSINESS STRATEGY
  • TABLE 53. GLOBAL GENOMICS MARKET: PRODUCT SATISFACTION
  • TABLE 54. GLOBAL GENOMICS MARKET: RANKING
  • TABLE 55. GLOBAL GENOMICS MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 56. GLOBAL GENOMICS MARKET: MERGER & ACQUISITION
  • TABLE 57. GLOBAL GENOMICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 58. GLOBAL GENOMICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 59. GLOBAL GENOMICS MARKET: INVESTMENT & FUNDING
  • TABLE 60. GLOBAL GENOMICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 61. GLOBAL GENOMICS MARKET: LICENSE & PRICING